Is Fisher & Paykel Healthcare Corp Ltd a better buy than ResMed Inc.?

Shares in Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) are smashing ResMed Inc. (CHESS) (ASX:RMD).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As markets roll with volatility in 2016, now more than ever is the time to focus on the huge global force of the healthcare industry.

For respiratory product producers Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) and ResMed Inc. (CHESS) (ASX: RMD) demand is still growing rapidly as populations age and China's middle class market grows.

But of the two companies it's Fisher & Paykel Healthcare that has been the true shooting star. Shares have rocketed 39% in the last 12 months, compared to ResMed's 7% rise:

160115 RP - RMD vs FPH

The rise reflects Fisher & Paykel Healthcare's rapidly improving financial performance and growing margins. For the most recent six months the company grew revenue by 20%, compared to ResMed's 9% growth.

Fisher & Paykel Healthcare may be small and nimble relative to ResMed, but the improving results are the product of excellent long term planning and reinvestment. The company has lowered production costs by setting up manufacturing in Mexico and moving to a direct sales distribution strategy in the United States which helped to add almost 3% to the company's gross margin for the six months to 30 September, 2015.

Revenue growth is set to continue and the company anticipates full year operating revenue growth of 19% over the 2015 financial year to NZ$800 million. Within three years this is expected to top NZ$1 billion.

But with a current price-to-earnings (p/e) ratio of 35, compared to ResMed on 21, is FPH a better buy today?

If each continues growing at its respective current rate over the next three years, in my view investors could be reasonably indifferent between the two at their current values.

  ResMed Inc.¹ Fisher & Paykel Healthcare
Six month revenue growth 9% 20%
Gross profit margin 58% 63%
Price-to-earnings ratio 21.6 35.5
Current dividend Yield 1.6% 1.8%

Source: Company announcements. Notes: ¹Qtr 4, FY15 + Qtr1, FY16

The two companies are subject to similar business risks, including currency exposure from the large percentage of earnings generated outside of Australia, and each company runs the perpetual risk of brand damage for unexpected product recalls.

However, the strong growth and increasing brand recognition of Fisher & Paykel Healthcare wins me over and I would be willing to pay the premium over ResMed to own the company.

Foolish takeaway

Fisher & Paykel Healthcare is a company I would love to own to gain exposure to the growing healthcare industry. It's a fantastic defensive, well run, high margin business with a rapidly growing market. It understandably commands a premium share price.

Motley Fool contributor Regan Pearson has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »